Cargando…
Tuftsin Promotes an Anti-Inflammatory Switch and Attenuates Symptoms in Experimental Autoimmune Encephalomyelitis
Multiple sclerosis (MS) is a demyelinating autoimmune disease mediated by infiltration of T cells into the central nervous system after compromise of the blood-brain barrier. We have previously shown that administration of tuftsin, a macrophage/microglial activator, dramatically improves the clinica...
Autores principales: | Wu, Muzhou, Nissen, Jillian C., Chen, Emily I., Tsirka, Stella E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328491/ https://www.ncbi.nlm.nih.gov/pubmed/22529957 http://dx.doi.org/10.1371/journal.pone.0034933 |
Ejemplares similares
-
Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis
por: Bhasin, Madhuri, et al.
Publicado: (2007) -
Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis
por: Bao, Zheng, et al.
Publicado: (2019) -
Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
por: Thompson, Kaitlyn K., et al.
Publicado: (2018) -
The Experimental Autoimmune Encephalomyelitis Disease Course Is Modulated by Nicotine and Other Cigarette Smoke Components
por: Gao, Zhen, et al.
Publicado: (2014) -
Anti-tumour effect of the physiological tetrapeptide, tuftsin.
por: Nishioka, K.
Publicado: (1979)